HRP20201751T1 - Pripravak za liječenje akni - Google Patents
Pripravak za liječenje akni Download PDFInfo
- Publication number
- HRP20201751T1 HRP20201751T1 HRP20201751TT HRP20201751T HRP20201751T1 HR P20201751 T1 HRP20201751 T1 HR P20201751T1 HR P20201751T T HRP20201751T T HR P20201751TT HR P20201751 T HRP20201751 T HR P20201751T HR P20201751 T1 HRP20201751 T1 HR P20201751T1
- Authority
- HR
- Croatia
- Prior art keywords
- preparation
- decanediol
- salix alba
- extract
- ethylhexyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 5
- 208000002874 Acne Vulgaris Diseases 0.000 title claims 2
- 206010000496 acne Diseases 0.000 title claims 2
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 claims 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 4
- 229940084038 salix alba bark extract Drugs 0.000 claims 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 241001278097 Salix alba Species 0.000 claims 3
- 239000000516 sunscreening agent Substances 0.000 claims 3
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims 2
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims 2
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims 2
- 229960005193 avobenzone Drugs 0.000 claims 2
- 229940073499 decyl glucoside Drugs 0.000 claims 2
- 229940008099 dimethicone Drugs 0.000 claims 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims 2
- 229960001679 octinoxate Drugs 0.000 claims 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 2
- 235000012239 silicon dioxide Nutrition 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- 239000004408 titanium dioxide Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 239000000230 xanthan gum Substances 0.000 claims 2
- 229920001285 xanthan gum Polymers 0.000 claims 2
- 229940082509 xanthan gum Drugs 0.000 claims 2
- 235000010493 xanthan gum Nutrition 0.000 claims 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- CENPSTJGQOQKKW-UHFFFAOYSA-N 2,4,6-tris(4-phenylphenyl)-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=CC=C(C=2N=C(N=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=C1 CENPSTJGQOQKKW-UHFFFAOYSA-N 0.000 claims 1
- 239000004910 After sun product Substances 0.000 claims 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- 229910000397 disodium phosphate Inorganic materials 0.000 claims 1
- 235000019800 disodium phosphate Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 claims 1
- 229940120668 salicin Drugs 0.000 claims 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 claims 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 claims 1
- -1 serum Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000007762 w/o emulsion Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (9)
1. Pripravak namijenjen upotrebi u antibakterijskom i/ili protuupalnom liječenju akni, naznačen time što sadrži 1,2-dekandiol i ekstrakt kore drveta Salix alba, gdje ekstrakt kore drveta Salix alba sadrži ukupnu koncentraciju derivata salicilne kiseline izraženih kao salicin od najmanje 20% (tež./tež.).
2. Pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 1, naznačen time što je udio 1,2-dekandiola u rasponu između 0,001% (tež./tež.) i 10% (tež./tež.), osobito u rasponu između 0,01% (tež./tež.) i 5% (tež./tež.), na osnovi ukupne mase pripravka.
3. Pripravak namijenjen upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što je udio ekstrakta kore drveta Salix alba u rasponu između 0,001% (tež./tež.) i 10% (tež./tež.), po mogućnosti između 0,01% (tež./tež.) i 5% (tež./tež.), na osnovi ukupne mase pripravka.
4. Pripravak namijenjen upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se omjer između ekstrakta kore drveta Salix alba i 1,2-dekandiola kreće između 1:10 i 10:1; po mogućnosti između 1:5 i 5:1, poželjnije 1:1.
5. Pripravak namijenjen upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što je pripravak u obliku sustava tenzida, emulzije vode u ulju, emulzije ulja u vodi, seruma, gela, ulja, vodene otopine, hidroalkoholne otopine, bezvodnih štapića, kompaktnog temeljnog pudera, losiona, mlijeka, kreme za sunčanje, proizvoda za upotrebu nakon sunčanja ili maskirnog proizvoda.
6. Pripravak namijenjen upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što dodatno sadrži uobičajena pomoćna sredstva i aditive.
7. Pripravak namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 6, naznačen time što je krema za sunčanje koja sadrži 0,3% (tež./tež.) ekstrakta kore drveta Salix alba, 0,3% (tež./tež.) 1,2-dekandiola, do 10% (tež./tež.) smjese metilen-bisbenzotriazolil-tetrametilbutilfenol (46-55%)/voda (33,9-47,7%)/decil-glukozid (6-10%)/propilen-glikol 0,2-0,6%)/ksantanska guma (0,1-0,5%), do 0,5% (tež./tež.) magnezijevog aluminijevog silikata, do 5% (tež./tež.) smjese titanijev dioksid (75%)/silicijev dioksid (10%)/dimetikon (15%), do 8% (tež./tež.) etilheksil-metoksicinamata, do 5% (tež./tež.) dikaprilil-karbonata, do 5% (tež./tež.) avobenzona, do 2% (tež./tež.) etilheksil-triazona.
8. Pripravak namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 6, naznačen time što je krema za sunčanje koja sadrži 0,3% (tež./tež.) ekstrakta kore drveta Salix alba, 0,3% (tež./tež.) 1,2-dekandiola, do 10% (tež./tež.) smjese voda (37-46%)/trisbifeniltriazin (47-53%)/decil-glukozid (6,5-8,5%)/dinatrijev fosfat (0,2%-0,6%)/butilen-glikol (0,2%-0,6%)/ksantanska guma (0,1%-0,3%), do 0,5% (tež./tež.) magnezijevog aluminijevog silikata, do 5% (tež./tež.) smjese titanijev dioksid (75%)/silicijev dioksid (10%)/dimetikon (15%)/do 8% (tež./tež.) etilheksil-metoksicinamata, do 5% (tež./tež.) dikaprilil-karbonata, do 5% (tež./tež.) avobenzona, do 2% (tež./tež.) etilheksil-triazona.
9. Pripravak namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 6, naznačen time što je gel koji sadrži 0,5% (tež./tež.) ekstrakta kore drveta Salix alba, 0,5% (tež./tež.) 1,2-dekandiola, do 2% (tež./tež.) kaprilil-glikola, do 3% (tež./tež.) poliakrilatnog umreženog polimera-6, do 1% (tež./tež.) nikotinamida.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201515000576A | 2015-02-27 | 2015-02-27 | |
| EP15000576.7A EP3061501A1 (en) | 2015-02-27 | 2015-02-27 | Composition for the treatment of acne |
| PCT/EP2016/000312 WO2016134846A1 (en) | 2015-02-27 | 2016-02-23 | Composition for the treatment of acne |
| EP19161351.2A EP3524255B1 (en) | 2015-02-27 | 2016-02-23 | Composition for the treatment of acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20201751T1 true HRP20201751T1 (hr) | 2020-12-25 |
Family
ID=52633039
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191011TT HRP20191011T1 (hr) | 2015-02-27 | 2019-06-04 | Pripravak za liječenje akni |
| HRP20201751TT HRP20201751T1 (hr) | 2015-02-27 | 2020-10-30 | Pripravak za liječenje akni |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191011TT HRP20191011T1 (hr) | 2015-02-27 | 2019-06-04 | Pripravak za liječenje akni |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20180021229A1 (hr) |
| EP (4) | EP3061501A1 (hr) |
| CN (2) | CN107257688A (hr) |
| DK (2) | DK3524255T3 (hr) |
| ES (2) | ES2731286T3 (hr) |
| HR (2) | HRP20191011T1 (hr) |
| HU (2) | HUE044021T2 (hr) |
| PL (2) | PL3261726T3 (hr) |
| PT (1) | PT3261726T (hr) |
| RU (1) | RU2718919C1 (hr) |
| SI (2) | SI3261726T1 (hr) |
| TR (1) | TR201908954T4 (hr) |
| WO (1) | WO2016134846A1 (hr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018226651A1 (en) * | 2017-06-05 | 2018-12-13 | The Procter & Gamble Company | Hair care compositions comprising materials that modify sebum |
| CN111511343A (zh) * | 2017-12-19 | 2020-08-07 | 帝斯曼知识产权资产管理有限公司 | 局部组合物 |
| JP7304933B2 (ja) * | 2018-07-18 | 2023-07-07 | シムライズ アーゲー | 洗剤組成物 |
| CN108553411B (zh) | 2018-07-25 | 2020-05-12 | 成都卓阳生物科技有限公司 | 壬二酸凝胶剂及其制备方法和应用 |
| US20220395451A1 (en) * | 2019-10-03 | 2022-12-15 | Beiersdorf Ag | Novel skin care composition |
| US20220331374A1 (en) * | 2019-10-03 | 2022-10-20 | Beiersdorf Ag | Novel skin care composition |
| US20230210761A1 (en) * | 2019-10-03 | 2023-07-06 | Beiersdorf Ag | Novel skin care composition |
| WO2021063531A1 (en) * | 2019-10-03 | 2021-04-08 | S-Biomedic | Novel skin care composition |
| CN114901242A (zh) * | 2019-10-03 | 2022-08-12 | S-生物医药有限公司 | 新的皮肤护理组合物 |
| CN114727945A (zh) * | 2019-11-21 | 2022-07-08 | 联合利华知识产权控股有限公司 | 化妆品组合物 |
| CN110893160B (zh) * | 2019-12-14 | 2022-04-26 | 广州尚妆优品生物科技有限公司 | 修复组合物 |
| CN114272298A (zh) * | 2021-11-12 | 2022-04-05 | 河南省农业科学院畜牧兽医研究所 | 一种柳树皮提取物、其复方制剂及应用 |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3173876A (en) | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
| US3276586A (en) | 1963-08-30 | 1966-10-04 | Rosaen Filter Co | Indicating means for fluid filters |
| US3546142A (en) | 1967-01-19 | 1970-12-08 | Amicon Corp | Polyelectrolyte structures |
| US3541006A (en) | 1968-07-03 | 1970-11-17 | Amicon Corp | Ultrafiltration process |
| US3541005A (en) | 1969-02-05 | 1970-11-17 | Amicon Corp | Continuous ultrafiltration of macromolecular solutions |
| US3813384A (en) | 1972-01-17 | 1974-05-28 | Asta Werke Ag Chem Fab | Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof |
| US3854770A (en) | 1972-11-20 | 1974-12-17 | Pioneer Coveralls Inc | Truck cover |
| US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4235236A (en) | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
| US4449983A (en) | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
| US4455143A (en) | 1982-03-22 | 1984-06-19 | Alza Corporation | Osmotic device for dispensing two different medications |
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| EP0174464B1 (de) | 1984-09-14 | 1990-01-03 | ASTA Pharma AG | Substituierte Benzylphthalazinon-Derivate |
| US5223493A (en) | 1984-12-28 | 1993-06-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| PH26882A (en) | 1985-07-30 | 1992-11-16 | Glaxo Group Ltd | Devices for administering medicaments to patients |
| ES2053678T3 (es) | 1987-11-13 | 1994-08-01 | Asta Medica Ag | Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular. |
| US5232919A (en) | 1987-11-13 | 1993-08-03 | Asta Pharma Aktiengesellschaft | Azelastine embonate and compositions which contain it |
| US5271946A (en) | 1988-04-20 | 1993-12-21 | Asta Pharma Aktiengesellschaft | Controlled release azelastine-containing pharmaceutical compositions |
| NZ234143A (en) | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| CA2121435C (en) | 1993-04-16 | 2002-01-22 | Sheila M. Ratnaraj | Aqueous pharmaceutical suspension and process for preparation thereof |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| US5420120A (en) | 1993-12-17 | 1995-05-30 | Alcon Laboratories, Inc. | Anti-inflammatory glucocorticoid compounds for topical ophthalmic use |
| US5897858A (en) | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
| DE4438588A1 (de) * | 1994-10-28 | 1996-05-02 | Beiersdorf Ag | Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren |
| US5921237A (en) | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5795894A (en) | 1995-05-02 | 1998-08-18 | Schering Corporation | Piperazino derivatives as neurokinn antagonists |
| US5719156A (en) | 1995-05-02 | 1998-02-17 | Schering Corporation | Piperazino derivatives as neurokinin antagonists |
| US5696267A (en) | 1995-05-02 | 1997-12-09 | Schering Corporation | Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| US5688960A (en) | 1995-05-02 | 1997-11-18 | Schering Corporation | Substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
| US5654316A (en) | 1995-06-06 | 1997-08-05 | Schering Corporation | Piperidine derivatives as neurokinin antagonists |
| BR9608997A (pt) | 1995-06-21 | 1999-06-29 | Asta Medica Ag | Cartucho para pó farmacêutico com dispositivo de medição integrado e intalador para medicamentos em pó |
| DE19523516C1 (de) | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19615577A1 (de) | 1996-04-19 | 1997-10-23 | Beiersdorf Ag | Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen |
| DE19617487A1 (de) | 1996-05-02 | 1997-11-06 | Merck Patent Gmbh | Geschmacksverbesserung von Arzneimittelwirkstoffen |
| US5691362A (en) | 1996-06-05 | 1997-11-25 | Schering-Plough Corporation | Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists |
| US5789422A (en) | 1996-10-28 | 1998-08-04 | Schering Corporation | Substituted arylalkylamines as neurokinin antagonists |
| US5783579A (en) | 1996-12-20 | 1998-07-21 | Schering Corporation | Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
| DE19814256A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
| US6260549B1 (en) | 1998-06-18 | 2001-07-17 | Clavius Devices, Inc. | Breath-activated metered-dose inhaler |
| JP2000012864A (ja) | 1998-06-22 | 2000-01-14 | Semiconductor Energy Lab Co Ltd | 半導体装置の作製方法 |
| US6270790B1 (en) | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| US6319513B1 (en) | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
| WO2000012135A1 (fr) | 1998-08-28 | 2000-03-09 | Eisai Co., Ltd | Compositions medicales presentant une amertume, etc., reduite |
| US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| US6165512A (en) | 1998-10-30 | 2000-12-26 | Fuisz Technologies Ltd. | Dosage forms containing taste masked active agents |
| US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| US6615826B1 (en) | 1999-02-26 | 2003-09-09 | 3M Innovative Properties Company | Slow spray metered dose inhaler |
| PL355101A1 (en) | 1999-11-18 | 2004-04-05 | Alcon Inc. | Use of h1 |
| AU2001231000A1 (en) | 2000-01-19 | 2001-07-31 | Pharmaceutical Discovery Corporation | Dry powder formulations of antihistamine for nasal administration |
| US6427688B1 (en) | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
| DE10034328A1 (de) | 2000-07-14 | 2002-01-31 | Fribad Cosmetics Gmbh | Kosmetisches Mittel zur äußeren Anwendung auf der Haut und deren Verwendung |
| US7776315B2 (en) | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| US6620438B2 (en) | 2001-03-08 | 2003-09-16 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists |
| WO2002056876A2 (en) | 2001-01-18 | 2002-07-25 | Medpointe Healthcare Inc. | Treatment for snoring |
| FR2823671B1 (fr) * | 2001-04-23 | 2004-01-09 | Dermaconcept Jmc | Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide |
| US20030013675A1 (en) | 2001-05-25 | 2003-01-16 | Boehringer Ingelheim Pharma Kg | Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases |
| US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
| US6779520B2 (en) | 2001-10-30 | 2004-08-24 | Iep Pharmaceutical Devices Inc. | Breath actuated dry powder inhaler |
| US6723348B2 (en) | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
| DE10206759A1 (de) | 2002-02-19 | 2003-08-28 | Dragoco Gerberding Co Ag | Synergistische Mischungen von 1,2-Alkandiolen |
| MXPA04009617A (es) | 2002-04-04 | 2005-01-11 | Pfizer Prod Inc | Comprimido masticable con sabor agradable. |
| DE10215553A1 (de) * | 2002-04-09 | 2003-12-24 | Robugen Gmbh | Weidenextrakt |
| MXPA05010422A (es) | 2003-05-02 | 2005-11-04 | Warner Lambert Co | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad. |
| US20040265372A1 (en) | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| DE10341179A1 (de) * | 2003-09-06 | 2005-03-31 | Beiersdorf Ag | Wirkstoffkombination gegen Akne |
| RU2259814C2 (ru) * | 2003-10-30 | 2005-09-10 | Халюта Алексей Иванович | Крем для кожи |
| SE0303569L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | DPI för avlämning av fuktkänsliga medikament |
| SE0303570L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| SE0303571D0 (sv) | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive medicaments |
| FR2904765A1 (fr) * | 2006-08-10 | 2008-02-15 | Oreal | Film a dissolution amelioree et produit cosmetique le contenant |
| EP1915982A1 (de) * | 2006-10-20 | 2008-04-30 | Symrise GmbH & Co. KG | Verwendung von 1,2-Decandiol zur Sebumreduktion bzw. zur Unterstützung des Eindringens von Wirkstoffen in Hautbereiche, sowie kosmetische und/oder dermatologische Zubereitungen umfassend 1,2-Decandiol |
| US9687429B2 (en) * | 2007-06-20 | 2017-06-27 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing low concentrations of botanicals |
| WO2009046116A1 (en) * | 2007-10-01 | 2009-04-09 | Dennis Gross | Skin care products containing multiple enhancers |
| KR20110015462A (ko) * | 2008-06-05 | 2011-02-15 | 리차드 이. 데이비슨 | 나노은을 포함하는 여드름 치료 조성물 및 이의 용도 |
| US20100129465A1 (en) * | 2008-07-03 | 2010-05-27 | Roger Blotsky | Methods and Compositions Related to Acne Treatment |
| FR2948565B1 (fr) * | 2009-07-30 | 2011-10-28 | Expanscience Lab | Composition cosmetique pour le traitement de l'acne comprenant un extrait petidique de schizandra |
| DE102010012384A1 (de) | 2010-03-22 | 2011-09-22 | Beiersdorf Ag | Hautfreundliche Wirkstoffkombination gegen Akne |
| US9056063B2 (en) * | 2012-03-13 | 2015-06-16 | James E. Hanson | Natural sunscreen composition |
| DE102012223401A1 (de) * | 2012-12-17 | 2014-06-18 | Henkel Ag & Co. Kgaa | Emulsion mit antibakteriellem Wirkstoff |
| CN103816165B (zh) * | 2014-03-11 | 2019-03-01 | 北京德默高科医药技术有限公司 | 一种治疗痤疮的组合物 |
-
2015
- 2015-02-27 EP EP15000576.7A patent/EP3061501A1/en not_active Withdrawn
-
2016
- 2016-02-23 CN CN201680011621.7A patent/CN107257688A/zh active Pending
- 2016-02-23 PT PT16706531T patent/PT3261726T/pt unknown
- 2016-02-23 CN CN202310169271.9A patent/CN116019751A/zh active Pending
- 2016-02-23 WO PCT/EP2016/000312 patent/WO2016134846A1/en active Application Filing
- 2016-02-23 DK DK19161351.2T patent/DK3524255T3/da active
- 2016-02-23 TR TR2019/08954T patent/TR201908954T4/tr unknown
- 2016-02-23 HU HUE16706531A patent/HUE044021T2/hu unknown
- 2016-02-23 RU RU2017130357A patent/RU2718919C1/ru active
- 2016-02-23 US US15/550,934 patent/US20180021229A1/en not_active Abandoned
- 2016-02-23 EP EP20193192.0A patent/EP3799933A1/en active Pending
- 2016-02-23 SI SI201630290T patent/SI3261726T1/sl unknown
- 2016-02-23 PL PL16706531T patent/PL3261726T3/pl unknown
- 2016-02-23 HU HUE19161351A patent/HUE051654T2/hu unknown
- 2016-02-23 PL PL19161351T patent/PL3524255T3/pl unknown
- 2016-02-23 EP EP19161351.2A patent/EP3524255B1/en active Active
- 2016-02-23 ES ES16706531T patent/ES2731286T3/es active Active
- 2016-02-23 SI SI201630986T patent/SI3524255T1/sl unknown
- 2016-02-23 EP EP16706531.7A patent/EP3261726B1/en active Active
- 2016-02-23 ES ES19161351T patent/ES2835302T3/es active Active
- 2016-02-23 DK DK16706531.7T patent/DK3261726T3/da active
-
2018
- 2018-12-05 US US16/210,902 patent/US20190175467A1/en not_active Abandoned
-
2019
- 2019-06-04 HR HRP20191011TT patent/HRP20191011T1/hr unknown
-
2020
- 2020-10-30 HR HRP20201751TT patent/HRP20201751T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20191011T1 (hr) | 2019-08-23 |
| EP3061501A1 (en) | 2016-08-31 |
| RU2718919C1 (ru) | 2020-04-15 |
| WO2016134846A1 (en) | 2016-09-01 |
| SI3261726T1 (sl) | 2019-09-30 |
| EP3524255A1 (en) | 2019-08-14 |
| HUE051654T2 (hu) | 2021-03-29 |
| EP3261726B1 (en) | 2019-04-17 |
| PL3261726T3 (pl) | 2019-10-31 |
| ES2835302T3 (es) | 2021-06-22 |
| CN107257688A (zh) | 2017-10-17 |
| ES2731286T3 (es) | 2019-11-14 |
| SI3524255T1 (sl) | 2021-02-26 |
| US20180021229A1 (en) | 2018-01-25 |
| EP3799933A1 (en) | 2021-04-07 |
| EP3261726A1 (en) | 2018-01-03 |
| US20190175467A1 (en) | 2019-06-13 |
| DK3524255T3 (da) | 2020-11-09 |
| CN116019751A (zh) | 2023-04-28 |
| PT3261726T (pt) | 2019-06-25 |
| HUE044021T2 (hu) | 2019-09-30 |
| EP3524255B1 (en) | 2020-09-09 |
| DK3261726T3 (da) | 2019-06-24 |
| PL3524255T3 (pl) | 2021-03-08 |
| TR201908954T4 (tr) | 2019-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201751T1 (hr) | Pripravak za liječenje akni | |
| ES2693756T3 (es) | Emulsiones de enjuague bucal | |
| ES2700784T3 (es) | Extracto de partes aéreas de Gynandropsis gynandra o Cleome gynandra y composiciones cosméticas, dermatológicas o farmacéuticas que lo comprenden | |
| ES2615239T3 (es) | Composición cosmética que comprende partículas de aerogel de sílice, un tensioactivo géminis y una sustancia grasa sólida o pastosa | |
| RU2016103715A (ru) | Лечение папулопустулезной розацеа ивермектином | |
| RU2016116831A (ru) | Композиция | |
| CN102697698A (zh) | 婴儿护臀霜 | |
| UA75461U (uk) | Засіб для профілактики стоматологічних захворювань | |
| ES2377226T3 (es) | Combinaciones de principios activos a base de un extracto de fruto de anÃs y un extracto de té blanco | |
| CN103816088B (zh) | 一种儿童爽肤水 | |
| JP5244294B2 (ja) | 皮膚バリア機能向上用の皮膚外用剤 | |
| BRPI1010907B8 (pt) | emulsão de óleo-em-água de mometasona e propileno-glicol | |
| CN102188355A (zh) | 一种保湿止痒润肤乳液 | |
| CN106236642A (zh) | 一种沐浴露 | |
| RU2008127223A (ru) | Средство и безалкогольный напиток для профилактики последствий и уменьшения проявлений острой алкогольной интоксикации | |
| ES2387438B1 (es) | Composición de una crema para el tratamiento de la piel | |
| US20160136067A1 (en) | Antifungal Deodorant | |
| ES2562085B1 (es) | Crema para el tratamiento de pieles con estados descamativos y procedimiento de fabricación de dicha crema | |
| BR112017019102A2 (pt) | formulação cosmética antioxidante para uso tópico compreendendo uma associação de extratos vegetais, e uso da mesma | |
| CN105362138A (zh) | 一种含有茶叶提取物的润肤露 | |
| CZ21572U1 (cs) | Bylinný přípravek na bázi konopí | |
| HRP20140386T1 (hr) | Pripravak namijenjen primjeni na koži i njegova upotreba | |
| PL417610A1 (pl) | Maseczka kosmetyczna o właściwościach przeciwstarzeniowych, uelastyczniających, odżywczych i regeneracyjnych | |
| PL422524A1 (pl) | Wieloskładnikowy preparat do regenerowania paznokci dłoni i stóp oraz sposób wytwarzania tego preparatu | |
| Souza et al. | Photochemoprotective effect of Byrsonima crassifolia extract against oxidative damage induced by UVA radiation in fibroblast cell culture |